Evidence map›Paper›PMID 20541252›Full record

SynthesisLancet (London, England)2010

Common genetic determinants of vitamin D insufficiency: a genome-wide association study.

Thomas J Wang, Feng Zhang, J Brent Richards, Bryan Kestenbaum, Joyce B van Meurs, Diane Berry, Douglas P Kiel, Elizabeth A Streeten, Claes Ohlsson, Daniel L Koller and 66 more

Registry-linked trialOpen access · greenAbstract readMeta-AnalysisMulticenter StudyComment
In one paragraph

Synthesis in Lancet (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03318029 (A Systems Biology Approach to the Interaction Between Vitamin D Supplementation and Sunlight Exposure in Brazilian Women Living in Opposite Latitudes), which is not on this map. Cited by 783 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
783citing papers in PubMed, 15 pooled it
71.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03318029 nacompletednot on this mapstarted 2016, after this paper: background citation

A Systems Biology Approach to the Interaction Between Vitamin D Supplementation and Sunlight Exposure in Brazilian Women Living in Opposite Latitudes (The D-SOL Study).

TypeinterventionalSponsorUniversity of SurreyRan2016 to 2017Enrolled136ConditionsVitamin D DeficiencyArmsVitamin D supplementation, Placebo
3 · Its place in the literature

Who cites it

783 citing papers in PubMed, 15 syntheses or guidelines pooled it, 1,535 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Vitamin DBMC infectious diseases · 2023
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article

723 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

76 authors at 20 institutions in 8 countries.

Thomas J WangDivision of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. tjwang@partners.org
Feng Zhang
J Brent Richards
Bryan Kestenbaum
Joyce B van Meurs
Diane Berry
Douglas P Kiel
Elizabeth A Streeten
Claes Ohlsson
Daniel L Koller
Leena Peltonen
Jason D Cooper
Paul F O'Reilly
Denise K Houston
Nicole L Glazer
Liesbeth Vandenput
Munro Peacock
Julia Shi
Fernando Rivadeneira
Mark I McCarthy
Pouta Anneli
Ian H de Boer
Massimo Mangino
Bernet Kato
Deborah J Smyth
Sarah L Booth
Paul F Jacques
Greg L Burke
Mark Goodarzi
Ching-Lung Cheung
Myles Wolf
Kenneth Rice
David Goltzman
Nick Hidiroglou
Martin Ladouceur
Nicholas J Wareham
Lynne J Hocking
Deborah Hart
Nigel K Arden
Cyrus Cooper
Suneil Malik
William D Fraser
Anna-Liisa Hartikainen
Guangju Zhai
Helen M Macdonald
Nita G Forouhi
Ruth J F Loos
David M Reid
Alan Hakim
Elaine Dennison
Yongmei Liu
Chris Power
Helen E Stevens
Laitinen Jaana
Ramachandran S Vasan
Nicole Soranzo
Jörg Bojunga
Bruce M Psaty
Mattias Lorentzon
Tatiana Foroud
Tamara B Harris
Albert Hofman
John-Olov Jansson
Jane A Cauley
Andre G Uitterlinden
Quince Gibson
Marjo-Riitta Järvelin
David Karasik
David S Siscovick
Michael J Econs
Stephen B Kritchevsky
Jose C Florez
John A Todd
Josee Dupuis
Elina Hyppönen
Timothy D Spector
King's College London · GBErasmus MC · NLIndiana University – Purdue University Indianapolis · USUniversity of Cambridge · GBUniversity of Gothenburg · SEUniversity of Washington · USWake Forest University · USAddenbrooke's Hospital · GBUniversity College London · GBUniversity of Aberdeen · GBBoston University · USFinnish Institute for Health and Welfare · FIHarborview Medical Center · USHebrew SeniorLife · USJewish General Hospital · CATufts University · USUniversity of Maryland, Baltimore · USUniversity of Oxford · GBAgency for Science, Technology and Research · SGBroad Institute · US

Funding

Type 1 Diabetes Genetics ConsortiumU01DK062418 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICH, STEPHEN S. · 2002 to 2007
$59.8M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSIONM01RR000750 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI RODRIGUEZ, HENRY · 1985 to 2008
$25.5M
ZORVIRAX ORAL SUSPENSION FOR SEVERE CHILDHOOD HERPES VIRUS INFECTIONSM01RR000069 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 1985 to 2008
$22.1M
GENETICS OF BONE LOSS AND BONE STRENGTH IN WOMEN &MENP01AG018397 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ECONS, MICHAEL J · 2000 to 2010
$19.1M
Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D, TAYLOR, SIMEON I. · 2005 to 2019
$17.3M
RISK FACTORS FOR VERTEBRAL FRACTURE AND BONE LOSSR01AR041398 · NIAMS · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI KIEL, DOUGLAS P. · 1991 to 2025
$16.1M
The Aging Kidney: Chronic Injury, Impaired Functions and Clinical OutcomesR01AG027002 · NIA · TUFTS MEDICAL CENTER · PI PARIKH, SAMIR M, SARNAK, MARK J · 2005 to 2022
$7.3M
WGA Study to Identify Genetic Variants Associated with CV Events in CHSR01HL087652 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2007 to 2009
$5.1M
CHS Events Follow-up StudyU01HL080295 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2005 to 2008
$4.6M
Genetics of cardiovascular risk factors in large founder population birth controlR01HL087679 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HIRSCHHORN, JOEL N · 2007 to 2009
$4.0M
Genetic Determinants of Visceral AdiposityR01AG032098 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LIU, YONGMEI · 2009 to 2013
$3.4M
Arthritis Research UKBiotechnology and Biological Sciences Research Council G20234CIHRDepartment of Health PHCS/C4/4/016Intramural NIH HHSMedical Research Council G0000934Medical Research Council G0400546Medical Research Council G0500539Medical Research Council G0600705Medical Research Council G0601653Medical Research Council G0701863Medical Research Council G0801462Medical Research Council MC_U106179471Medical Research Council MC_U106188470Medical Research Council MC_UP_A100_1003Medical Research Council MC_UP_A620_1014NCRR NIH HHS M01 RR000069NCRR NIH HHS M01RR00069NCRR NIH HHS M01 RR000750NCRR NIH HHS M01 RR-00750NHGRI NIH HHS HHSN268200782096CNHLBI NIH HHS 5R01HL087679-02NHLBI NIH HHS N01 HC015103NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC035129NHLBI NIH HHS N01 HC045133NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC075150NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085080NHLBI NIH HHS N01 HC085081NHLBI NIH HHS N01 HC085082NHLBI NIH HHS N01 HC085083NHLBI NIH HHS N01 HC085084NHLBI NIH HHS N01 HC085085NHLBI NIH HHS N01 HC085086NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS N01-HC-55222NHLBI NIH HHS N01-HC-75150NHLBI NIH HHS N01-HC-85079NHLBI NIH HHS N01-HC-85080NHLBI NIH HHS N01-HC-85081NHLBI NIH HHS N01-HC-85082NHLBI NIH HHS N01-HC-85083NHLBI NIH HHS N01-HC-85086NHLBI NIH HHS N02 HL064278NHLBI NIH HHS N02-HL-6-4278NHLBI NIH HHS R01 HL084443NHLBI NIH HHS R01 HL087652NHLBI NIH HHS R01 HL087679NHLBI NIH HHS U01 HL080295NIAMS NIH HHS R01 AR041398NIAMS NIH HHS R01 AR046838NIAMS NIH HHS R01 AR46838NIA NIH HHS AG14759NIA NIH HHS N01 AG062101NIA NIH HHS N01 AG062103NIA NIH HHS N01 AG062106NIA NIH HHS N01-AG-6-2101NIA NIH HHS N01-AG-6-2103NIA NIH HHS N01-AG-6-2106NIA NIH HHS P01 AG018397NIA NIH HHS P01 AG-18397NIA NIH HHS R01 AG014759NIA NIH HHS R01 AG027002NIA NIH HHS R01 AG029364NIA NIH HHS R01-AG029364NIA NIH HHS R01 AG032098NIA NIH HHS R01-AG032098NIA NIH HHS R01 AG041517NIA NIH HHS R01 AR/AG 41398NIDDK NIH HHS DK063491NIDDK NIH HHS P30 DK063491NIDDK NIH HHS P30 DK072488NIDDK NIH HHS R01 DK033651NIDDK NIH HHS U01 DK062418NIMH NIH HHS 1RL1MH083268-01NIMH NIH HHS RL1 MH083268Wellcome Trust 061858Wellcome Trust 068545/Z/02Wellcome Trust 076113Wellcome Trust 079895Wellcome Trust GR069224
6 · The paper itself

Abstract

backgroundVitamin D is crucial for maintenance of musculoskeletal health, and might also have a role in extraskeletal tissues. Determinants of circulating 25-hydroxyvitamin D concentrations include sun exposure and diet, but high heritability suggests that genetic factors could also play a part. We aimed to identify common genetic variants affecting vitamin D concentrations and risk of insufficiency.

methodsWe undertook a genome-wide association study of 25-hydroxyvitamin D concentrations in 33 996 individuals of European descent from 15 cohorts. Five epidemiological cohorts were designated as discovery cohorts (n=16 125), five as in-silico replication cohorts (n=9367), and five as de-novo replication cohorts (n=8504). 25-hydroxyvitamin D concentrations were measured by radioimmunoassay, chemiluminescent assay, ELISA, or mass spectrometry. Vitamin D insufficiency was defined as concentrations lower than 75 nmol/L or 50 nmol/L. We combined results of genome-wide analyses across cohorts using Z-score-weighted meta-analysis. Genotype scores were constructed for confirmed variants.

findingsVariants at three loci reached genome-wide significance in discovery cohorts for association with 25-hydroxyvitamin D concentrations, and were confirmed in replication cohorts: 4p12 (overall p=1.9x10(-109) for rs2282679, in GC); 11q12 (p=2.1x10(-27) for rs12785878, near DHCR7); and 11p15 (p=3.3x10(-20) for rs10741657, near CYP2R1). Variants at an additional locus (20q13, CYP24A1) were genome-wide significant in the pooled sample (p=6.0x10(-10) for rs6013897). Participants with a genotype score (combining the three confirmed variants) in the highest quartile were at increased risk of having 25-hydroxyvitamin D concentrations lower than 75 nmol/L (OR 2.47, 95% CI 2.20-2.78, p=2.3x10(-48)) or lower than 50 nmol/L (1.92, 1.70-2.16, p=1.0x10(-26)) compared with those in the lowest quartile.

interpretationVariants near genes involved in cholesterol synthesis, hydroxylation, and vitamin D transport affect vitamin D status. Genetic variation at these loci identifies individuals who have substantially raised risk of vitamin D insufficiency.

fundingFull funding sources listed at end of paper (see Acknowledgments).

Indexed as

Polymorphism, Single NucleotideCanadaChromosomes, Human, Pair 11Chromosomes, Human, Pair 4Cohort StudiesDietary SupplementsEuropeGenetic Predisposition to DiseaseGenome-Wide Association StudyHeterozygoteHomozygoteHumansImmunoassayInternational CooperationLinkage DisequilibriumSeasons25-hydroxyvitamin DVitamin D

Identifiers

PMID20541252
PMCPMC3086761
OpenAlexW2162258804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.